Wire Stories

Japan Alternative Lending Market Business Databook 2023: 75+ KPIs on Market Size, End User, Finance Model, Payment Instrument, Loan Type and Demographics 2018-2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Alternative Lending Market Business and Investment Opportunities Databook - 75+ KPIs on…

Asia-Pacific Functional Genomics Market: Analysis and Forecasts 2023-2033: Collaborations Foster Innovations, Efficient Instruments Shape the Future of the Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia-Pacific Functional Genomics Market: Analysis and Forecast, 2023-2033" report has been added to…

Philippines Conversational Commerce Market Projected to Reach US$9.5 Billion by 2028 with Strong Growth in AI-Based Virtual Assistants Segment – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Philippines Conversational Commerce Market Intelligence and Future Growth Dynamics Databook - 75+ KPIs…

Taiwan Ecommerce Market Databook 2023 Featuring Books.com.tw, ibon Mart, Momoshop, PChome, Shopee – Forecasts to 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Taiwan Ecommerce Market Opportunities Databook - 100+ KPIs on Ecommerce Verticals (Shopping, Travel,…

Nidec Announces that Takisawa Consolidates Shares and Becomes a Wholly Owned Subsidiary of Nidec

KYOTO, Japan--(BUSINESS WIRE)--Nidec Corporation (TOKYO: 6594; OTC US: NJDCY) (the “Company”) announced today that Takisawa…

Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of DFP-14323

TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. As presented at 2022…

Elliptic Labs Signs Software License Contract with New Smartphone Customer

OSLO, Norway--(BUSINESS WIRE)--#AIVirtualProximitySensor--Elliptic Labs (OSE: ELABS), a global AI software company and the world leader…

Investor Group Submits Value-Enhancing Shareholder Proposals for Consideration at Samsung C&T Corporation’s 2024 Annual General Meeting

Investor Group Consists of Local and Foreign Long-Term Shareholders, Including ANDA Asset Management, City of…

Sirius Therapeutics Begins Phase 1 Clinical Trial of Next-Generation, Long-Acting Factor XI siRNA Anticoagulant for Treatment of Thromboembolic Disorders

SAN DIEGO & SHANGHAI--(BUSINESS WIRE)--Sirius Therapeutics, announced it has dosed the first subject in a…